CIK 0001326190 · Non-accelerated filer<br>Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 202726770
- Phone
- 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- 4 Open-market sale Chief Scientific Officer sold 5,462 shares at $12.00 ($65,546)
- 4 Open-market sale Chief Scientific Officer sold 37,352 shares at $12.00 ($448,254)
- 4 Open-market sale Director sold 17,610 shares at $11.75 ($206,944)
- 4 Option exercise Director acquired 279 shares (option exercise)
- 4 Open-market buy Director bought 1,000 shares at $8.00 ($8,000)
- 4 Shares withheld for taxes President and CEO gave up 3,008 shares (to pay taxes)
- 4 Open-market buy Director bought 1,200 shares at $4.50 ($5,400)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Shares withheld for taxes President and CEO gave up 3,008 shares (to pay taxes)
- SC 13G/A Stake Amended Statement of Ownership
- 4 Shares withheld for taxes President and CEO gave up 3,007 shares (to pay taxes)
- SC 13G Stake Amended Statement of Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Open-market sale Chief Medical Officer sold 30,000 shares at $7.52 ($225,600)
- 4 Shares withheld for taxes President and CEO gave up 3,007 shares (to pay taxes)
- 4/A Derivatives Options or other derivatives
- 5 Insider Annual Insider Trading Report
Page 16 of 74 · 1,467 filings